163 related articles for article (PubMed ID: 20412845)
1. Synthesis, characterization and in vitro evaluation of a bone targeting delivery system for salmon calcitonin.
Bhandari KH; Newa M; Uludag H; Doschak MR
Int J Pharm; 2010 Jul; 394(1-2):26-34. PubMed ID: 20412845
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
3. Hexapeptide-conjugated calcitonin for targeted therapy of osteoporosis.
Liu Y; Yu P; Peng X; Huang Q; Ding M; Chen Y; Jin R; Xie J; Zhao C; Li J
J Control Release; 2019 Jun; 304():39-50. PubMed ID: 31054990
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated "universal" osteoclast targeting platform using calcitonin as a model drug.
Newa M; Bhandari KH; Tang L; Kalvapalle R; Suresh M; Doschak MR
Pharm Res; 2011 May; 28(5):1131-43. PubMed ID: 21301934
[TBL] [Abstract][Full Text] [Related]
5. PK/PD modelling of comb-shaped PEGylated salmon calcitonin conjugates of differing molecular weights.
Ryan SM; Frías JM; Wang X; Sayers CT; Haddleton DM; Brayden DJ
J Control Release; 2011 Jan; 149(2):126-32. PubMed ID: 20946924
[TBL] [Abstract][Full Text] [Related]
6. Conjugation of salmon calcitonin to a combed-shaped end functionalized poly(poly(ethylene glycol) methyl ether methacrylate) yields a bioactive stable conjugate.
Ryan SM; Wang X; Mantovani G; Sayers CT; Haddleton DM; Brayden DJ
J Control Release; 2009 Apr; 135(1):51-9. PubMed ID: 19168100
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization and biodistribution studies of (125)I-radioiodinated di-PEGylated bone targeting salmon calcitonin analogue in healthy rats.
Yang Y; Bhandari KH; Panahifar A; Doschak MR
Pharm Res; 2014 May; 31(5):1146-57. PubMed ID: 24357414
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterisation of a novel peptide delivery system: amphiphilic polyelectrolyte-salmon calcitonin nanocomplexes.
Cheng WP; Thompson C; Ryan SM; Aguirre T; Tetley L; Brayden DJ
J Control Release; 2010 Oct; 147(2):289-97. PubMed ID: 20705108
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and in vivo activity of salmon calcitonin coconjugated with lipid and polyethylene glycol.
Cheng W; Lim LY
J Pharm Sci; 2009 Apr; 98(4):1438-51. PubMed ID: 18704953
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of salmon calcitonin (sCT) enteric-coated capsule for enhanced absorption and GI tolerability in rats.
Wu L; Zhang G; Lu Q; Sun Q; Wang M; Li N; Gao Z; Sun Y; Li T; Han D; Yu X; Wang L; Sun W; Zhao D; Wu Y; Lu Y; Chen X
Drug Dev Ind Pharm; 2010 Mar; 36(3):362-70. PubMed ID: 19719396
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, characterization and in-vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety.
Cheng W; Lim LY
J Pharm Pharmacol; 2010 Mar; 62(3):296-304. PubMed ID: 20487211
[TBL] [Abstract][Full Text] [Related]
13. Improved intrapulmonary delivery of site-specific PEGylated salmon calcitonin: optimization by PEG size selection.
Youn YS; Kwon MJ; Na DH; Chae SY; Lee S; Lee KC
J Control Release; 2008 Jan; 125(1):68-75. PubMed ID: 18023905
[TBL] [Abstract][Full Text] [Related]
14. Imparting mineral affinity to fetuin by bisphosphonate conjugation: a comparison of three bisphosphonate conjugation schemes.
Gittens SA; Bansal G; Kucharski C; Borden M; Uludag H
Mol Pharm; 2005; 2(5):392-406. PubMed ID: 16196492
[TBL] [Abstract][Full Text] [Related]
15. Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.
Shah RB; Khan MA
J Pharm Sci; 2004 Feb; 93(2):392-406. PubMed ID: 14705196
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate conjugation to proteins as a means to impart bone affinity.
Uludag H; Kousinioris N; Gao T; Kantoci D
Biotechnol Prog; 2000; 16(2):258-67. PubMed ID: 10753453
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of HPβCD-PEG microparticles for salmon calcitonin administration via pulmonary delivery.
Tewes F; Gobbo OL; Amaro MI; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Mol Pharm; 2011 Oct; 8(5):1887-98. PubMed ID: 21882837
[TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary drug delivery of salmon calcitonin.
Deftos LJ; Nolan JJ; Seely BL; Clopton PL; Cote GJ; Whitham CL; Florek LJ; Christensen TA; Hill MR
Calcif Tissue Int; 1997 Oct; 61(4):345-7. PubMed ID: 9312206
[TBL] [Abstract][Full Text] [Related]
19. Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
Aguirre TAS; Aversa V; Rosa M; Guterres SS; Pohlmann AR; Coulter I; Brayden DJ
J Control Release; 2016 Sep; 238():242-252. PubMed ID: 27480451
[TBL] [Abstract][Full Text] [Related]
20. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]